Pages that link to "Q33392766"
Jump to navigation
Jump to search
The following pages link to Stem-cell gene therapy for the Wiskott-Aldrich syndrome (Q33392766):
Displaying 50 items.
- Advances of gene therapy for primary immunodeficiencies (Q26742031) (← links)
- Clinical development of gene therapy: results and lessons from recent successes (Q26743393) (← links)
- Gene therapy: progress and predictions (Q26772109) (← links)
- Gene therapy through autologous transplantation of gene-modified hematopoietic stem cells (Q26851493) (← links)
- Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models (Q26859147) (← links)
- Gene therapy for primary immunodeficiencies (Q26864856) (← links)
- Retroviral integrations in gene therapy trials (Q26991660) (← links)
- Gene therapy for skin diseases (Q26994703) (← links)
- Hematopoietic stem cell engineering at a crossroads (Q27001570) (← links)
- Gene therapy on the move (Q27007012) (← links)
- The diagnostic approach to monogenic very early onset inflammatory bowel disease (Q27015077) (← links)
- Current translational and clinical practices in hematopoietic cell and gene therapy (Q27024456) (← links)
- Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors (Q28077919) (← links)
- Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012 (Q28708928) (← links)
- Inducible apoptosis as a safety switch for adoptive cell therapy (Q29617710) (← links)
- Preparation and testing of quaternized chitosan nanoparticles as gene delivery vehicles (Q30893643) (← links)
- Inherited platelet disorders: a clinical approach to diagnosis and management (Q33396427) (← links)
- Foamy virus vector-mediated gene correction of a mouse model of Wiskott-Aldrich syndrome (Q33399020) (← links)
- Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome (Q33399943) (← links)
- Wiskott-Aldrich syndrome: a comprehensive review (Q33406620) (← links)
- Gene therapy for PIDs: progress, pitfalls and prospects (Q33406944) (← links)
- Comparison of insulators and promoters for expression of the Wiskott-Aldrich syndrome protein using lentiviral vectors (Q33408529) (← links)
- Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity (Q33413888) (← links)
- Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments (Q33415221) (← links)
- Diagnosis and treatment of inherited thrombocytopenias. (Q33422383) (← links)
- Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia (Q33424820) (← links)
- Concise review: lessons learned from clinical trials of gene therapy in monogenic immunodeficiency diseases (Q33552027) (← links)
- Image-guided intrathymic injection of multipotent stem cells supports lifelong T-cell immunity and facilitates targeted immunotherapy (Q33556917) (← links)
- Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites (Q33586934) (← links)
- Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients (Q33671980) (← links)
- Vector integration and tumorigenesis (Q33782783) (← links)
- Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts (Q33863533) (← links)
- Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells. (Q33891707) (← links)
- Clinical trials for stem cell therapies (Q33898451) (← links)
- Cutaneous manifestations of DOCK8 deficiency syndrome (Q33921708) (← links)
- Analyzing the number of common integration sites of viral vectors--new methods and computer programs (Q34055417) (← links)
- Gene therapy for hemoglobinopathies: the state of the field and the future (Q34204480) (← links)
- Gammaretroviral vectors: biology, technology and application (Q34223822) (← links)
- Molecular mechanisms of retroviral integration site selection (Q34249653) (← links)
- Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence. (Q34249667) (← links)
- Thymidine kinase suicide gene-mediated ganciclovir ablation of autologous gene-modified rhesus hematopoiesis (Q34295186) (← links)
- Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. (Q34356904) (← links)
- Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy (Q34356914) (← links)
- Linear amplification mediated PCR--localization of genetic elements and characterization of unknown flanking DNA. (Q34385265) (← links)
- Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases (Q34401676) (← links)
- Gene therapy for inherited immunodeficiency (Q34419791) (← links)
- Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease (Q34449867) (← links)
- Gene therapy of chronic granulomatous disease: the engraftment dilemma (Q34473374) (← links)
- Progress and prospects of gene therapy clinical trials for the muscular dystrophies. (Q34497471) (← links)
- Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors (Q34576925) (← links)